Skip to main content

Apnea, Sleep

2
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

MSD
MSDIreland - Ballydine
1 program
1
MK-7288Phase 11 trial
Active Trials
NCT01092780Completed56Est. May 2011
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
1
MK-7288Phase 1
Olympus
OlympusPA - Center Valley
1 program
RFA treatmentN/A1 trial
Active Trials
NCT02349893Completed56Est. Jun 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MSDMK-7288
OlympusRFA treatment

Clinical Trials (2)

Total enrollment: 112 patients across 2 trials

Pharmacodynamics and Efficacy of MK-7288 in Adults With Sleep Apnea (MK-7288-010)

Start: May 2010Est. completion: May 201156 patients
Phase 1Completed
NCT02349893OlympusRFA treatment

Radiofrequency Ablation for Multi-level Obstructive Sleep Apnea: A Single-arm, Multicenter Study

Start: Feb 2015Est. completion: Jun 202156 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.